Maus M et al. Grb2 associated binder 2 couples B-cell receptor to cell survival. (2009) CELLULAR SIGNALLING 0898-6568 1873-3913 21 2 220-227,
239659
Szakcikk (Folyóiratcikk) | Tudományos[239659]
Liu Zhongliang et al. Analysis of the microRNA and mRNA expression profile of ricin toxin-treated RAW264.7 cells reveals that miR-155-3p suppresses cell inflammation by targeting GAB2. (2021) TOXICOLOGY LETTERS 0378-4274 1879-3169 347 67-77
Shi X.-Y. et al. MiR-98-5p regulates proliferation and metastasis of MCF-7 breast cancer cells by targeting Gab2. (2019) EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES 1128-3602 2284-0729 23 7 2847-2855
Dong Baoxia et al. T cell activation is reduced by the catalytically inactive form of protein tyrosine phosphatase SHP-2. (2015) INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE 1940-5901 8 4 6568-6577
Ding Chen-Bo et al. Structure and function of Gab2 and its role in cancer (Review). (2015) MOLECULAR MEDICINE REPORTS 1791-2997 1791-3004 12 3 4007-4014
Hu S et al. Growth factor receptor bound protein 2-associated binder 2, a scaffolding adaptor protein, negatively regulates host immunity against tuberculosis. (2014) AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY 1044-1549 1535-4989 51 4 575-585
You Z-H et al. Research on signaling pathways reconstruction by integrating high content RNAi screening and functional gene network. (2013) Megjelent: Intelligent Computing Theories and Technology. ICIC 2013. pp. 1-10
Zhang S et al. Gab2 Signaling in Breast Cancer. (2011) ZHONGGUO SHENGWU HUAXUE YU FENZI SHENGWU XUEBAO / CHINESE JOURNAL OF BIOCHEMISTRY AND MOLECULAR BIOLOGY 1007-7626 27 4 300-304
Zhong XL et al. Common variant in GAB2 is associated with late-onset Alzheimer's disease in Han Chinese. (2011) CLINICA CHIMICA ACTA 0009-8981 1873-3492 412 5-6 446-449
Pan XL et al. The Gab2 in signal transduction and its potential role in the pathogenesis of Alzheimer's disease. (2010) NEUROSCIENCE BULLETIN 1673-7067 1995-8218 26 3 241-246
Rövid közlemény (Folyóiratcikk) | Tudományos[21914754] [Admin láttamozott]
Czaller I et al. The natural history of hereditary angioedema and the impact of treatment with human C1-inhibitor concentrate during pregnancy: a long-term survey. (2010) EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY 0301-2115 1872-7654 152 1 44-49,
1440615
Szakcikk (Folyóiratcikk) | Tudományos[1440615]
Jindal A.K. et al. Management of pregnancy in hereditary angioedema in a resource constrained setting: Our experience at Chandigarh, North India. (2022) IMMUNOBIOLOGY 0171-2985 1878-3279 227 2
Bork K. et al. Inheritance Pattern of Hereditary Angioedema Indicates Mutation-Dependent Selective Effects During Early Embryonic Development. (2022) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE 2213-2198 2213-2201 10 4 1029-1037
Radojicic Cristine. Guidelines for management of hereditary angioedema: What is new? What is missing?. (2022) ALLERGY AND ASTHMA PROCEEDINGS 1088-5412 43 1 12-19
Busse P.J. et al. US HAEA Medical Advisory Board 2020 Guidelines for the Management of Hereditary Angioedema. (2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE 2213-2198 2213-2201 9 1 132-150
Valerieva Anna et al. Therapeutic management of hereditary angioedema: past, present, and future. (2021) BALKAN MEDICAL JOURNAL 2146-3123 2146-3131 38 2 89-103
Nasca M.R. et al. The Influence of Pregnancy on the Clinical Evolution and Prognosis of Pre-Existing Inflammatory and Autoimmune Skin Disorders and Their Management. (2021) DERMATOLOGY 1018-8665 1421-9832 237 5 771-785
Kardum Zeljka et al. Successful treatment with Cinryze (R) replacement therapy of a pregnant patient with hereditary angioedema: a case report. (2021) JOURNAL OF MEDICAL CASE REPORTS 1752-1947 15 1
West J.B. et al. Preventive Treatment of Hereditary Angioedema: A Review of Phase III Clinical Trial Data for Subcutaneous C1 Inhibitor and Relevance for Patient Management. (2021) CLINICAL THERAPEUTICS 0149-2918 1879-114X 43 12 2154-2166.e1
Clark Kathryn J. et al. Obstetric Anesthetic Management for Parturients with Hereditary Angioedema: A Case Report and Suggested Protocol. (2021) PAIN MEDICINE 1526-2375 22 8 1878-1882
Batlle Amanda Ribeiro et al. Management of hereditary angioedema type I and homozygous MTHFR mutation during pregnancy. (2021) ALLERGOLOGIA ET IMMUNOPATHOLOGIA 0301-0546 1578-1267 49 4 1-3
Bernstein J.A. et al. Hormonal Effects on Urticaria and Angioedema Conditions. (2021) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE 2213-2198 2213-2201 9 6 2209-2219
Jindal A.K. et al. Successful perioperative management of three patients with hereditary angioedema without C1 esterase inhibitor therapy: A developing country perspective. (2020) IMMUNOBIOLOGY 0171-2985 1878-3279 225 6
Demina D.V. et al. Successful long-term prophylaxis of hereditary pregnancy-associated angioedema with plasmaderived c1-inhibitor concentrate: A case report. (2020) Medical Immunology (Russia) 1563-0625 2313-741X 22 6 1215-1220
Bobrikova E.N. et al. Significance of Individual Management Plan for the Patients with Hereditary Lymphangioedema during Pregnancy and Lactation, and in Newborns. (2020) Medical Immunology (Russia) 1563-0625 2313-741X 22 3 577-584
Napolitano Maddalena et al. Hereditary angioedema type III, recurrent pregnancy loss and heterozygous MTHFR mutation. (2020) DERMATOLOGIC THERAPY 1396-0296 33 6
Brooks Joel P. et al. Experience with Intravenous Plasma-Derived C1-Inhibitor in Pregnant Women with Hereditary Angioedema: A Systematic Literature Review. (2020) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE 2213-2198 2213-2201 8 6 1875-1880.e3
Moldovan Dumitru et al. Safety of recombinant human C1 esterase inhibitor for hereditary angioedema attacks during pregnancy. (2019) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY: IN PRACTICE 2213-2198 2213-2201 7 8 2938-2940
Hakl Roman et al. Treatment of Hereditary Angioedema Attacks with Icatibant and Recombinant C1 Inhibitor During Pregnancy. (2018) JOURNAL OF CLINICAL IMMUNOLOGY 0271-9142 1573-2592 38 7 810-815
Calaforra-Mendez Susana et al. Successful long-term prophylaxis with human plasma-derived C1 inhibitor in planning and carrying out pregnancy. (2018) ALLERGOLOGY INTERNATIONAL 1323-8930 1440-1592 67 1 144-146
Porebski Grzegorz et al. Management of hereditary angioedema with C1-deficiency - consensus statement of the HAE Section of the Polish Society of Allergology. Part II: treatment, follow-up and special situations. (2018) Alergologia Polska - Polish Journal of Allergology 2353-3854 5 2 109-120
Dalgic Ceyda Tunakan et al. In Vitro Fertilization Using Luteinizing Hormone-Releasing Hormone Injections Resulted in Healthy Triplets without Increased Attack Rates in a Hereditary Angioedema Case. (2018) CASE REPORTS IN IMMUNOLOGY 2090-6609 2018
Bernstein Jonathan A. Human plasma-derived C1 esterase inhibitor for on-demand or prophylaxis treatment of patients with hereditary angioedema: intravenous and subcutaneous formulations. (2018) EXPERT OPINION ON ORPHAN DRUGS 2167-8707 6 3 237-245
Satomura Atsushi et al. Comparison of the Frequency of Angioedema Attack, before and during Pregnancy, in a Patient with Type I Hereditary Angioedema. (2018) INTERNAL MEDICINE 0918-2918 1349-7235 57 5 751-755
Moza Andreea et al. The Management of Pregnancy with Hereditary Angioedema. (2017) Megjelent: 13TH CONFERENCE OF THE ROMANIAN-GERMAN SOCIETY OF OBSTETRICS AND GYNECOLOGY pp. 184-188
Saguer Inmaculada Martinez et al. Successful management of hereditary angioedema during pregnancy in a patient with heterozygous MTHFR mutation. (2017) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 1081-1206 1534-4436 118 6 734-735
Fox James et al. Safety of a C1-inhibitor concentrate in pregnant women with hereditary angioedema. (2017) ALLERGY AND ASTHMA PROCEEDINGS 1088-5412 38 Los Angeles 216-221
Machado A M et al. Pregnancy and Postpartum in Hereditary Angioedema With C1 Inhibitor Deficit in Women Who Have No Access to Therapy. (2017) JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY 1018-9068 1698-0808 27 5 322-323
Craig Timothy et al. Efficacy and safety of an intravenous C1-inhibitor concentrate for long-term prophylaxis in hereditary angioedema. (2017) ALLERGY AND RHINOLOGY 2152-6575 2152-6567 8 1 E13-E19
Sokszerzős vagy csoportos szerzőségű szakcikk (Folyóiratcikk) | Tudományos[26718906] [Nyilvános]
Bygum Anette et al. Use of a C1 Inhibitor Concentrate in Adults aeyen65 Years of Age with Hereditary Angioedema: Findings from the International Berinert(A (R)) (C1-INH) Registry. (2016) DRUGS & AGING 1170-229X 1179-1969 33 11 819-827
Sokszerzős vagy csoportos szerzőségű szakcikk (Folyóiratcikk) | Tudományos[26358567] [Nyilvános]
Gonzalez-Quevedo T et al. Management of Pregnancy and Delivery in Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency. (2016) JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY 1018-9068 1698-0808 26 3 161-167
Zanichelli A et al. Icatibant Exposure During Pregnancy in a Patient With Hereditary Angioedema. (2015) JOURNAL OF INVESTIGATIONAL ALLERGOLOGY AND CLINICAL IMMUNOLOGY 1018-9068 1698-0808 25 6 447-449
Kuhlen James L et al. Hereditary angioedema: Special consideration in children, women of childbearing age, and the elderly. (2015) ALLERGY AND ASTHMA PROCEEDINGS 1088-5412 36 6 425-432
Markovič AS et al. Smjernice za dijagnostikui liječenje hereditarnog angioedema: Guidelines for the diagnosis and treatment of hereditary angioedema. (2014) LIJECNICKI VJESNIK 0024-3477 136 5-6 117-129
Bork K. Pasteurized and nanofiltered, plasma-derived C1 esterase inhibitor concentrate for the treatment of hereditary angioedema. (2014) IMMUNOTHERAPY 1750-743X 1750-7448 6 5 533-551
Bork Konrad et al. Treatment with C1-esterase inhibitor concentrate in type I or II hereditary angioedema: A systematic literature review. (2013) ALLERGY AND ASTHMA PROCEEDINGS 1088-5412 34 4 312-327
Castelli Roberto et al. Therapeutic options for patients with angioedema due to C1-inhibitor deficiencies: from pathophysiology to the clinic. (2013) IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY 0892-3973 1532-2513 35 1 181-190
Zanichelli Andrea et al. Therapeutic management of hereditary angioedema due to C1 inhibitor deficiency. (2013) EXPERT REVIEW OF CLINICAL IMMUNOLOGY 1744-666X 1744-8409 9 5 477-488
Hemperly SE et al. Recent advances in the management of hereditary angioedema. (2013) JOURNAL OF THE AMERICAN OSTEOPATHIC ASSOCIATION 0098-6151 113 7 546-555
Bork K et al. Overview of hereditary angioedema caused by C1-inhibitor deficiency: Assessment and clinical management. (2013) EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY 1764-1489 0397-9148 45 1 7-16
Chan W et al. Management of hereditary angioedema with C1-inhibitor concentrate during two successive pregnancies. (2013) INTERNATIONAL JOURNAL OF GYNECOLOGY AND OBSTETRICS 0020-7292 120 2 189-190
Bouillet Laurence et al. Hereditary Angioedema in Women Specific Challenges. (2013) IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA 0889-8561 33 4 505-511
Geng B et al. HAE Update: Special considerations in the female patient with hereditary angioedema. (2013) ALLERGY AND ASTHMA PROCEEDINGS 1088-5412 34 1 13-18
Xu Ying-Yang et al. Clinical features of hereditary angioedema in Chinese patients: New findings and differences from other populations. (2013) EUROPEAN JOURNAL OF DERMATOLOGY 1167-1122 1952-4013 23 4 500-504
Schatz M et al. Asthma and Allergic Diseases during Pregnancy. (2013) Megjelent: Middleton's Allergy: Principles and Practice: Eighth Edition pp. 951-969
Zuraw Bruce L et al. A focused parameter update: Hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. (2013) JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 0091-6749 1097-6825 131 6 1491-1493.e25
Shum Mili et al. Successful C1 inhibitor prophylaxis during zenker diverticulum repair in a patient with hereditary angioedema. (2012) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 1081-1206 1534-4436 108 2 126-128
Lang David M et al. International consensus on hereditary and acquired angioedema. (2012) ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY 1081-1206 1534-4436 109 6 395-402
Zuraw Bruce L et al. Hereditary angioedema with normal C1 inhibitor function: Consensus of an international expert panel. (2012) ALLERGY AND ASTHMA PROCEEDINGS 1088-5412 33 6 S145-S156
Bork Konrad. Human pasteurized C1-inhibitor concentrate for the treatment of hereditary angioedema due to C1-inhibitor deficiency. (2011) EXPERT REVIEW OF CLINICAL IMMUNOLOGY 1744-666X 1744-8409 7 6 723-733
Bowen Tom. Hereditary angioedema: beyond international consensus - circa December 2010-The Canadian Society of Allergy and Clinical Immunology Dr. David McCourtie Lecture. (2011) ALLERGY, ASTHMA AND CLINICAL IMMUNOLOGY 1710-1484 1710-1492 7
Csuka D et al. Functional analysis of the mannose-binding lectin complement pathway in normal pregnancy and preeclampsia. (2010) JOURNAL OF REPRODUCTIVE IMMUNOLOGY 0165-0378 87 1-2 90-96,
1435451
Szakcikk (Folyóiratcikk) | Tudományos[1435451]
Sidorova Sidorova I.S. et al. The complement system in preeclampsia-complicated pregnancy. (2021) AKUSHERSTVO I GINEKOLOGIIA - MOSKVA 0002-3906 2021 8 5-12
Wagdy M Amer et al. Pregnancy-induced low serum Ficolin levels may underlie the development of Pre-eclampsia and predict it. (2020) The Egyptian Journal of Fertility of Sterility 2536-9768 24 3 9-19
Pierik E. et al. Dysregulation of Complement Activation and Placental Dysfunction: A Potential Target to Treat Preeclampsia?. (2020) FRONTIERS IN IMMUNOLOGY 1664-3224 10
Larsen J.B. et al. Lectin pathway proteins of the complement system in normotensive pregnancy and pre-eclampsia. (2019) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 81 4
Sheng Yan-Ran et al. Insights of Efferocytosis in Normal and Pathological Pregnancy. (2019) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 82 2 p. e13088
Koucky M et al. Low maternal serum concentrations of mannose-binding lectin are associated with the risk of shorter duration of pregnancy and lower birthweight. (2018) SCANDINAVIAN JOURNAL OF IMMUNOLOGY 0300-9475 1365-3083 88 1
He Yingdong et al. Clinical value of detection of complement system related factors in preeclampsia. (2017) CHINESE JOURNAL OF LABORATORY MEDICINE 1009-9158 40 9 667-671
Madhukaran SP et al. Role of collectins and complement protein Cl q in pregnancy and parturition. (2016) IMMUNOBIOLOGY 0171-2985 1878-3279 221 11 1273-1288
Rawat P et al. Identification of potential protein biomarkers for early detection of pregnancy in cow urine using 2D DIGE and label free quantitation. (2016) CLINICAL PROTEOMICS 1542-6416 1559-0275 13 1
He Y et al. Expression of the complement system's activation factors in plasma of patients with early/late-onset severe pre-eclampsia. (2016) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 76 3 205-211
Agostinis ChIAra et al. Complement component C1q as potential diagnostic but not predictive marker of preeclampsia. (2016) AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY 1046-7408 1600-0897 76 6 475-481
